New gel injection aims to soothe sore tendons
NCT ID NCT06681051
First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 5 times
Summary
This study is testing a gel called OSTENIL TENDON to see if it safely reduces pain and improves movement in people with tendon problems. Researchers will enroll 84 adults with one of four types of tendinopathy. The main goal is to measure pain changes three months after treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients over 18 years of age with symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band) and a recommendation for OSTENIL® TENDON treatment.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient aged between 18 and 99 years * Diagnosis of symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band) * Physician's recommendation to use OSTENIL® TENDON prior to recruitment * Signed informed consent Exclusion Criteria: * Presence of any contra-indication or precautionary condition listed in the instructions for use, i.e., * Ascertained hypersensitivity to any of the OSTENIL® TENDON constituents * Known pregnancy or breast feeding * Acute trauma * Use of the following treatments (the given time intervals refer to the date of inclusion): * Local\* OSTENIL® TENDON or other hyaluronic acid (HA) treatment within the last 6 months * Local\* platelet-rich plasma (PRP) treatment within the last 3 months * Local\* corticosteroid treatment (without time restriction) * Local\* extracorporeal shock wave therapy (ESWT) within the last 4 weeks * Local\* phytotherapy (e.g., Traumeel®) within the last 4 weeks * Local\* surgical intervention (without time restriction) * Systemic corticosteroid treatment within the last 4 weeks * Repeated use of non-steroidal anti-inflammatory drugs (NSAID) and/or other analgesics within the last week * Physiotherapy (therapeutic exercises and physical therapy), ortheses, transcutaneous electrical nerve stimulation (TENS) or acupuncture within the last week * Diagnosis of chronic inflammatory disease (e.g. rheumatoid arthritis, Bechterew disease, Crohn's disease, etc.) prior to inclusion * Participation in a clinical investigation within the last 6 months * Vulnerable patient (individual who is unable to fully understand all aspects of the study that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response \[including persons needing legally designated representatives, illiterate persons or persons with insufficient knowledge of local language\]) (\* local refers to the treatment of the study-relevant tendon)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Patellar tendinopathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ATOS MVZ meviva Berlin
COMPLETEDBerlin, 10627, Germany
-
Gemeinschaftspraxis Dr. Bierke
COMPLETEDBerlin, 14197, Germany
-
Orthopädie am Kiesteich
RECRUITINGBerlin, 13589, Germany
Contact Email: •••••@•••••
-
Orthopädische Gemeinschaftspraxis ÜBAG
RECRUITINGBerlin, State of Berlin, 14195, Germany
-
Orthopädische Praxis Dr. Fischer
COMPLETEDPotsdam, 14482, Germany
-
Orthopädisches Versorgungszentrum und Interdisziplinäres Schmerzzentrum Zehlendorf
RECRUITINGBerlin, State of Berlin, 14195, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound stiffness scans put tendon pain under the microscope
- Can collagen shots around the heel tendon speed recovery?
- Which injection eases arm pain better: steroid or Anti-Inflammatory?
- Sound waves vs. teen knee pain: a new test
- Mind over elbow: can beliefs predict how tennis elbow patients respond to treatment?
- Tendon pain showdown: which injection works better?